Relation between the stability of dental implants and two biological markers during the healing period: a prospective clinical study by Choknapa Tirachaimongkol et al.
RESEARCH Open Access
Relation between the stability of dental
implants and two biological markers during
the healing period: a prospective clinical
study
Choknapa Tirachaimongkol1, Peraphan Pothacharoen2, Peter A. Reichart3 and Pathawee Khongkhunthian1*
Abstract
Objectives: The purposes of this study were to examine the correlation between the stability of dental implants
and bone formation markers during the healing period and to monitor the stability of dental implants using the
resonance frequency analysis (RFA) method. The null hypothesis of the study is no correlation between the stability
of dental implant and bone formation markers.
Methods: The study is a prospective clinical study during the 3-month healing period of implant. At implant
placement (PW Plus, Nakhon Pathom, Thailand) and after 1, 2, 3, 4, 6, 8, 10, and 12 weeks, RFA assessments were
performed and gingival (GCF)/peri-implant crevicular fluids (PICF) were collected from ten patients. The level of
osteocalcin (OC) was measured by using ELISA kits, and the level of alkaline phosphatase (ALP) activity was measured
by colorimetric analysis. Repeated measures analysis of variance, the Friedman test, the Mann-Whitney U test, and the
Pearson correlation were performed for data analysis.
Results: There was a statistical decrease in the mean implant stability quotient (ISQ) values between 1 and 3 weeks
(P < 0.05). The ISQ values recovered to the initial values at 4 weeks. There was no statistical difference in the ALP
level at each measurement, while there was a statistical increase in the OC level at 6, 8, 10, and 12 weeks when
compared with 1 week (P < 0.05). There was a significant correlation between ALP levels and ISQ values (r = 0.226,
P < 0.05). There was a statistically significant correlation between OC levels and ISQ values at 1–12 weeks (r = 0.245,
P < 0.05).
Conclusions: The ISQ values were weakly correlated with both ALP and OC. The three-thread-design implant showed
a high stability through healing period.
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Background
Dental implants have shown a high success rate for re-
habilitation of edentulous patients if certain conditions
are met during treatment. Nevertheless, the risk of fail-
ure remains difficult to predict. The achievement of
osseointegration depends on many factors, such as a
suitable host, biocompatible materials, careful surgery,
and an appropriate healing time [1].
The primary stability comes from the mechanical an-
chorage between the bone tissue and the pitch region of
the implant immediately after implantation. The second-
ary stability comes from the formation of new vital bone,
which replaces the gap between the local bone and the
implant surface and replaces the necrotic bone.
The external morphology of the dental implant is a
factor which leads to the mechanical engagement of the
implant with the bone. Three-thread-design dental im-
plants consist of three different thread designs. The first
design is the micro-thread, or supra-fine thread, which is
on the coronal third of the implant fixture and is attached
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to the cortical bone. These small, fine threads are designed
for force distribution, an increase in the bone-implant
contact area and a decrease in the force concentration at
the abutment-implant connection area. The second design
is the reverse buttress thread, which is on the middle third
of the implant fixture. This design increases the retention
between the implant and spongy bone and produces re-
sistance to compressive force. The third design, the con-
densed thread, is located at the apical third of the implant
fixture. The thinness at the beginning of this thread and
an increase in thickness along the implant fixture are de-
signed for the soft spongy bone condensability [2].
Osseointegration, a continuous process, represents the
coupling of the osteoclast and osteoblast activity for
bone repair, formation, and adaptation to function [3, 4].
Implant-bone integration is separated into three phe-
nomena. The first phenomenon is distance osteogenesis.
Distance osteogenesis means that bone formation takes
place from the local bone toward the implant surface.
This event is anticipated to happen in cortical bone heal-
ing [5]. The second phenomenon is contact osteogen-
esis, in which bone formation takes place from the
implant surface toward the local bone. This osteogenesis
consists of the early phase of osteogenic cell migration,
osteoconduction, and de novo bone formation. The de
novo bone formation at a solid surface has four stages.
The first stage is secretion of the two noncollagenous
proteins, osteopontin, and bone sialoprotein. The second
stage is calcium phosphate nucleation, which consists of
the calcium binding at the calcium binding sites of these
proteins. The third stage is the crystal growth phase. The
last stage of de novo bone formation is derived from
collagen production and subsequent collagen mineralization.
Finally, bone remodeling is the third phenomenon of
implant-bone integration [6].
Osteocalcin (OC) is the most plentiful noncollagenous
protein of the bone matrix. It is secreted from odonto-
blasts, osteocytes, and osteoblasts, in order to bind hy-
droxyapatite and calcium during matrix mineralization
[7]. It is one of the serological markers in the bone for-
mation process. Numerous studies have shown increased
OC levels in bone formation. However, increased OC
level relates more to osteoid formation than matrix
mineralization during bone formation [8–10]. Alkaline
phosphatase (ALP) is a membrane-bound glycoprotein.
Its function is catalyzing the hydrolysis of phosphate
monoesters at a basic pH level. Bone-specific alkaline
phosphatase (BALP) is known to be involved in bone
calcification. It is secreted by osteoblasts to provide a high
phosphate concentration at the osteoblast cell surface
during bone mineralization [11].
The measurement of implant stability is based on the
clinical, histological, biomechanical, and biochemical
approaches. The resonance frequency analysis (RFA), a
noninvasive clinical implant stability measurement, has
been used in many studies. Meta-analysis of 47 studies
has revealed a statistically significant correlation between
RFA and insertion torque [12]. Numerous clinical studies
have used the resonance frequency analysis technique on
various implant designs to determine implant stability
during the osseointegration period [13–20]. Evaluation of
peri-implant crevicular fluid (PICF), a noninvasive, clin-
ical, biochemical approach has been used to assess and to
predict the peri-implant tissue loss [21, 22].
The purposes of this study were to examine the correl-
ation between the stability of dental implants and bone
formation markers during the healing period and to
monitor the stability of dental implants during a 3-
month period using the resonance frequency analysis
method. The null hypothesis of the study is no correl-
ation between the stability of dental implant and bone
formation markers. Due to the three-thread-design of the
implants, the authors also aim to measure the average
implant stability quotient using RFA during the healing
period.
Methods
The study is a prospective clinical study during the 3-
month healing period of implant. The study was approved
by the Human Experimentation Committee, Faculty of
Dentistry, Chiang Mai University. The study outline is
shown in Fig. 1.
Patients
Ten patients, who were partially edentulous in the man-
dibular posterior region for whom a single nonsub-
merged implant was planned, participated in this study.
All of them presented at the Center of Excellence for
Dental Implantology, Faculty of Dentistry, Chiang Mai
University, Thailand, between February and August 2015.
The inclusion and exclusion criteria were shown in
Table 1.
At the examination, the patients were informed about
the study’s purposes, procedures, and possible risks and
signed an informed consent. Scaling of all the teeth and
oral hygiene instructions were performed for each
patient.
Surgical procedure
All surgical procedures were completed by the same im-
plant surgeon. After clinical and radiographic examin-
ation, the latter using periapical, panoramic and cone
beam computed tomography images, and 2 g of amoxi-
cillin for antibiotic prophylaxis were administered to the
patients 1 hour before surgery. One PW Plus® implant
(PW Plus, Nakhon Pathom, Thailand) per patient was
placed in the mature bone at bone level under local
anesthesia (4% articaine with epinephrine 1:100,000).
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Midcrestal and sulcular incisions around the teeth were
performed at the implant site. After full-thickness muco-
periosteal flap elevation, implant bed preparation was
started by using custom surgical stents. Ten PW Plus®
implants were placed according to the manufacturer’s
recommendations. After implant insertion and stability
measurement, the smooth (polished) healing abutment
was screwed to the implant and the flaps were sutured
using 4-0 polypropylene suture material. As post-operative
instructions, the patients were asked to abstain from
mechanical plaque control at the surgical sites, 0.12%
chlorhexidine mouthwash was prescribed for microbial
control, and 400 mg ibuprofen for analgesia.
RFA assessments
At implant placement and after 1, 2, 3, 4, 6, 8, 10, and
12 weeks, RFA assessments were performed using the
Osstell® ISQ (Integration Diagnostics AB, Goteborg,
Sweden) according to the manufacturer’s instructions. A
Smartpeg™ (type 47) (Integration Diagnostics AB) was
screwed to the implant using a Smartpeg mount. After
Smartpeg mount removal, the RFA assessment was per-
formed with the measurement probe on the handheld
Osstell® ISQ instrument. The measurement probe was
held close to the top of the SmartPeg without touching
it until the instrument emitted a beeping sound and the
implant stability quotient (ISQ) value presented. Two
Fig. 1 Timeline of the clinical study. I—implant site, T—contralateral posterior mandibular nonsurgical tooth
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Patients aged 25–65 years Presence of periodontal disease or periapical lesions
Ability to participate in this study History of bone augmentation at the implant site in the past 6 months
No systemic diseases (e.g., diabetes, osteoporosis, hypertension, etc.) History of tooth extraction at the implant site in the past 6 months
Nonsmokers A need for submersion of an implant
No contraindication for minor oral surgery Requirement for grafting of bone or soft tissue at the time of implant
insertion
No psychosis or psychiatric disorders Pregnancy or positive to pregnancy test
No uncontrolled bleeding disorders Postmenopausal women
No bisphosphonate, hormone replacement, or corticosteroid drug use Physical disorders which would interfere with the ability to maintain oral
health care
No anti-inflammatory drug use for 6 months before surgery
Never received radiotherapy of the head and neck region
Adequate oral hygiene (average modified sulcus bleeding index ≤1,
average modified plaque index ≤1)
Adequate bone volume to achieve the plan without other surgery
(bone height ≥12 mm, bone width ≥7 mm)
Existing healthy contralateral posterior mandibular tooth
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measurements were performed, one from the buccal dir-
ection and one from the mesial direction. The two ISQ
values were recorded.
GCF and PICF sample collection
To observe the level of two bone formation biomarkers
(alkaline phosphatase and osteocalcin) during the
osseointegration period compared with control group
using GCF from the first molar of the contralateral side
of implant position, the sample collection of GCF was
performed before the surgical procedure, immediately
after the surgical operation and after 1, 2, 3, 4, 6, 8, 10,
and 12 weeks. The PICF sample collection was per-
formed immediately after the surgical operation and
after 1, 2, 3, 4, 6, 8, 10, and 12 weeks by a single trained
operator. PICF samples were collected from the buccal
side of the implant healing abutment, and GCF samples
were collected from the buccal side of the contralateral
nonsurgical tooth. The GCF/PICF collecting techniques
were modified from the method of Ciantar and Caruana
[23]. Before collecting the samples, the sites were iso-
lated with cotton rolls, supragingival plaque was re-
moved by probe, and tissues were kept dry by gentle air
flow. Paper strips (Periopaper, Oraflow, Smithtown, NY,
USA) were inserted into the sulcus until resistance was
felt and left in place for 30 s. The volume of fluid was
immediately measured by Periotron 8000 (Periotron,
Oraflow). The paper strips containing the GCF/PICF
sample were kept in a 1.5-ml Eppendorf tube. The tube
was labeled and kept on ice and then was transferred to
−80 °C for storage until the analysis was performed.
Sample preparation and analysis
GCF/PICF in the Periopaper strip was eluted by adding
320 μl quantity of phosphate-buffered saline (PBS) into
the sample tube and incubated at 4 °C, overnight. The
eluted protein solution from each gingival fluid sample
was used for the biochemical analysis.
Total protein in the gingival fluid sample was mea-
sured by the Bradford analysis [24]. Briefly, a 10 μl vol-
ume of sample or protein standard (0–500 μg/ml) was
added into each well of a 96-well microplate and then
200 μl of Bradford working reagent were added to each
well. The microplate was shaken for 5 min. After that,
the absorbance was measured at 620 nm. The concen-
trations of total protein in the samples were detected
and calculated from a standard curve.
The level of OC was measured by using commercially
available ELISA kits (Human Osteocalcin Quantikine
ELISA Kit, R&D Systems, Inc., Minneapolis, MN, USA)
according to the manufacturer’s instructions. A 100 μl
volume of Assay Diluent RD1-117 (R&D Systems) was
added into each well of the microplate and then 50 μl of
standard (0–64 ng/ml) or sample was added to each
well. The microplate was incubated for 2 h at room
temperature on a horizontal orbital microplate shaker
(Labnet International, Inc., Edison, NJ, USA) set at
500 rpm. After that, the solutions were aspirated and
each well was washed with 400 μl of Wash Buffer (R&D
Systems). This step was repeated three times for a total
of four washes. Then, 200 μl of Human Osteocalcin
Conjugate were added into each well, and the solutions
were incubated for 2 h at room temperature on the
shaker. After that, the solutions were aspirated and
washed again. A 200 μl volume of substrate solution
(tetramethylbenzidine) was added into each well, and
the solutions were incubated for 30 min at room
Table 2 Profile of patients
Patient no. Age Sex Positiona Bone qualityb
1 34 Female 46 3
2 38 Female 36 3
3 43 Female 37 3
4 64 Male 46 2
5 30 Female 47 3
6 48 Female 36 2
7 57 Male 36 3
8 28 Female 46 3
9 33 Male 46 2
10 49 Female 46 3
aFDI tooth-numbering system
bLekholm et al. [36] bone classification
Table 3 ISQ values according to gender and bone quality
Time Day 0 1 week 2 weeks 3 weeks 4 weeks 6 weeks 8 weeks 10 weeks 12 weeks
Mean ISQ values 77.0 ± 1.32 65.6 ± 2.70a 70.5 ± 2.03a 72.1 ± 1.64a 74.2 ± 1.65 76.1 ± 1.33 78.1 ± 1.38 78.2 ± 1.32 79.6 ± 1.06
Gender
Male (n = 3) 77.0 ± 0.58 59.7 ± 4.62 71.7 ± 3.24 75.0 ± 1.89 75.3 ± 3.92 77.8 ± 2.17 80.2 ± 3.44 78.2 ± 3.35 79.5 ± 2.78
Female (n = 7) 77.0 ± 1.92 68.1 ± 3.00 70.0 ± 2.68 70.8 ± 2.08 73.7 ± 1.88 75.3 ± 1.67 77.2 ± 1.40 78.2 ± 1.46 79.6 ± 1.13
Bone qualitya
Type 2 (n = 3) 79.3 ± 1.86 60.7 ± 3.77 67.7 ± 4.60 74.5 ± 1.89 73.3 ± 3.32 76.0 ± 2.02 78.7 ± 3.37 77.3 ± 3.09 78.2 ± 2.20
Type 3 (n = 7) 76.0 ± 1.64 67.7 ± 3.34 71.7 ± 2.23 71.0 ± 2.15 74.6 ± 2.05 76.1 ± 1.79 77.9 ± 1.56 78.6 ± 1.51 80.1 ± 1.22
aLekholm et al. [36] bone classification
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temperature on the bench-top. Next, 50 μl of stop solu-
tion (2 N sulfuric acid) were added into each well. The
color in the wells changed from blue to yellow. After
that, the color solution in each well was measured at
450/540 nm within 30 min. The OC level in each sample
was calculated from a standard curve and normalized by
total protein.
The level of the ALP activity was measured by colori-
metric analysis. Briefly, 80 μl of sample solution were
added into each well of a 96-well microplate, and then a
mixture of 100 μl phosphate substrate solution (p-nitro-
phenyl phosphate) and 20 μl 1.5 M alkali buffer solution
were added to each well. The microplate was incubated
at 37 °C for 1 h. Next, 50 μl of stop solution (1 M NaOH)
were added into each well. After that, the absorbance was
measured at 620 nm. Known concentrations of ALP prod-
uct (p-nitrophenol) were prepared with the dilutions ran-
ging from 0 to 250 μM. The activity of ALP in the samples
were calculated from a standard curve and normalized by
total protein.
Data analysis
Data were analyzed by using SPSS 17.0 software (SPSS
Inc., Chicago, IL, USA). Repeated measures analysis of
variance was performed to evaluate the change in the
ISQ values at each measurement. The independent
samples t test was used to investigate the differences in
implant stability in the patients’ gender and bone quality.
The Friedman test, followed by the Wilcoxon signed-rank
test, was used to examine the differences in the crevicular
fluid volume, the OC, or the ALP levels in each measure-
ment. The Mann-Whitney U test was used to analyze the
differences between the biomarker levels in the control
and the test groups. The correlations between OC or ALP
levels and ISQ values were calculated using the Pearson
correlation coefficient. P values <0.05 were considered sta-
tistically significant.
Results
Ten patients, seven females, and three males, aged
42.4 ± 11.99 years (range, 28 to 64 years), with either a
first mandibular or second mandibular molar edentulous
area, who required a single nonsubmerged implant partici-
pated in this study, as shown in Table 2. The implants
used for all patients were 10 mm long and 5 mm in diam-
eter. All patients completed the follow-up. None of the

















Fig. 2 Change in the mean ISQ values over time. There was a statistically significant decrease in the mean ISQ values between 1 and 3 weeks
(P < 0.05). The ISQ values recovered to the initial ISQ values at 4 weeks and slight increased at 6, 8, 10, and 12 weeks
Table 4 Crevicular fluid volume
Time Day 0 1 week 2 weeks 3 weeks 4 weeks 6 weeks 8 weeks 10 weeks 12 weeks
Median (interquartile range)
CF volume (μl)
Tooth (control) 0.20 (0.23) 0.26 (0.25) 0.19 (0.20) 0.19 (0.50) 0.17 (0.33) 0.18 (0.08) 0.13 (0.24) 0.23 (0.42) 0.20 (0.17)
Implant (test) 0.26 (0.30) 0.25 (0.41) 0.16 (0.21) 0.17 (0.19) 0.18 (0.33) 0.13 (0.14) 0.10 (0.09) 0.10 (0.17) 0.12 (0.21)
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The mean ISQ values were shown in Table 3. There
was a statistically significant decrease in the mean ISQ
values between 1 and 3 weeks (P < 0.05). The ISQ values
recovered to the initial ISQ values at 4 weeks and slight
increased at 6, 8, 10, and 12 weeks (Fig. 2). There was a
significant increase in the mean ISQ values at 6, 8, 10,
and 12 weeks when compared with 3 weeks. The mean
lowest ISQ values, recorded at 1 week, were 65.6 ± 2.70.
According to the independent samples t test, there were
no statistically significant differences in the mean ISQ
values with gender and bone quality.
The median values of the GCF and PICF volume are
shown in Table 4. At the implant site (test group), the
PICF volume continuously decreased with time (Fig. 3).
However, according to the Friedman test, there were no
significant differences in the median values of the crevic-
ular fluid volume in the control or the test group at each
measurement.
Both ALP and OC molecules were detectable in GCF
and PICF samples. The median values of the ALP and
OC levels are shown in Table 5. In the control group,





















Fig. 3 Change in the median values of the GCF (control group) and PICF (test group) volume over time. In the test group, the PICF volume
continuously decreased with time (a). There were no significant differences in the median values of the crevicular fluid volume in either the
control group or the test groups at any measurement (b)
Table 5 Crevicular fluid ALP and OC levels




Tooth (control) 175 (215) 203 (308) 148 (269) 143 (112) 266 (427) 145 (96) 181 (148) 191 (263) 107 (128)
Implant (test) 230 (238) 139 (139) 157 (293) 108 (134) 166 (434) 179 (251) 147 (296) 157 (201) 151 (968)
OC level
(pg/μg protein)
Tooth (control) 30 (42) 19 (56) 40 (92) 31 (34) 29 (48) 23 (31) 50 (49) 40 (78) 28 (47)
Implant (test) 7 (15) 16 (69) 15 (81) 68 (46) 37 (79) 52 (105) 94 (292) 91 (87) 59 (94)
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levels at each measurement. In the test group (implant
site), the ALP level decreased at 1–4 weeks and then in-
creased at 6, 8, 10, and 12 weeks (Fig. 4). However, ac-
cording to the Friedman test, there was no statistically
significant difference in the ALP level of the test group
at each measurement. Furthermore, according to the
Mann-Whitney U test, there was no statistically signifi-
cant difference in the ALP level between the control and
the test group at each measurement.
At the implant site, the OC level continuously in-
creased with time. According to the Friedman followed
by Wilcoxon signed-rank tests, there was statistically sig-
nificant increase in the OC level at 6, 8, 10, and 12 weeks
when compared with 1 week (P < 0.05, Fig. 5). Further-
more, according to the Mann-Whitney U test, there was a
statistically significant difference in the OC level between
the control and the test group at 6, 8, 10, and 12 weeks.
Correlations between ALP or OC levels and ISQ
values were examined, as shown in Figs. 6 and 7. During
1–12 weeks, there was a statistically significant correl-
ation between ALP levels at the implant site and ISQ
values (r = 0.226; P < 0.05). There was a statistically sig-
nificant correlation between OC levels at the implant
site and ISQ values at 1–12 weeks (r = 0.245; P < 0.05).
Correlations between ALP and OC levels are shown in
Fig. 8. At all measurements from week 1 to week 12, the
ALP levels were moderately correlated with the OC
levels at the implant site, the control site, and the pooled
samples of the control and implant sites (r = 0.615,






































Fig. 4 Change in the median values of the ALP level over time. In the test group, the ALP level decreased at 1–4 weeks and then increased at 6,
8, 10, and 12 weeks. There was no statistically significant difference in the ALP level in either the control or the test groups at any measurement
Fig. 5 Change in the median values of the OC level over time. In the test group, the OC level continuously increased with time. There was a
statistically significant increase in the OC level at 6, 8, 10, and 12 weeks when compared with 1 week (P < 0.05)
Tirachaimongkol et al. International Journal of Implant Dentistry  (2016) 2:27 Page 7 of 11
Discussion
The results of this study show that, at the time of im-
plantation, the ISQ values ranged between 67.5 and 83.
The mean initial ISQ value was 77.0 ± 1.32. These
findings are in harmony with those of previous studies
[16, 18]. Tallarico et al. (2011) reported that the macro-
design of dental implant affects the primary anchorage
[16]. They suggested that the high initial ISQ value is a
factor in making decisions about immediate loading on
dental implants. The three-thread-design implants used in
this study showed a high primary stability (ISQ value ≥65
to 70).
In the first 3 weeks, the mean ISQ values decreased
and then increased and reached the initial values in the
fourth week. The values then constantly increased in the
following weeks. The lowest ISQ value in an implant
was 51.5, found in the first week, and the highest value
was 84, found in the tenth week. These results are in
harmony with the findings of other clinical studies in
that the ISQ values decreased within the first 3 weeks
after implantation, and then increased and reached the
initial values in the following weeks [17, 25]. These find-
ings advise the presence of an interval between primary
and secondary stability. An animal study, using a bone
chamber model, which investigated the different phases
of wound healing surrounding dental implants, showed
that in areas of primary stability at the pitch region of
the implant, osseointegration occurred after a resorptive
process [26]. Thus, the primary mechanical stability was
destroyed for a short period of time. However, the re-
sults of another study showed no difference in the ISQ
values over 12 weeks [18].
In considering the median values of the crevicular
fluid volume, it was demonstrated that the PICF volume
continuously decreased with time. This finding is in
harmony with the result of a recent clinical study that
Fig. 6 There were weakly significant and positive correlations
between the ALP or OC levels and ISQ values at all measurements
from week 1 to week 12. At the implant site, the ALP levels in nM/μg
protein (a) or the OC levels in pg/μg protein (b) were associated with
ISQ values
Fig. 7 Comparison between the trend of the biomarker levels and the trend of the ISQ values over time
Tirachaimongkol et al. International Journal of Implant Dentistry  (2016) 2:27 Page 8 of 11
investigated the differences between peri-implant and
periodontal wound healing [27]. That study showed
that PICF volume decreased significantly from week 1
to week 3. Alteration of the gingival fluid volume and
contents occur according to the condition of the tissues
surrounding the teeth. The presence of inflammation
increases the gingival fluid volume. Also, changes in
peri-implant crevicular fluid contents and volume re-
sult from the condition of the peri-implant tissue.
The main sources of ALP in GCF are neutrophils, bac-
teria within dental plaque, fibroblasts, and osteoblasts
[28]. Plagnat et al. [29] suggested that longitudinal moni-
toring of ALP in PICF might confirm its possible use as
a marker of implant failure. Considering the change in
the median values of the ALP level over time, in the test
group, the ALP level decreased at 1–4 weeks and then
increased at 6, 8, 10, and 12 weeks. These results are
similar to those of a previously reported animal study of
gene expression of ALP during the osseointegration
period [30]. However, no significant differences in the
ALP level were noted over time. This may be due to the
variation of ALP sources in PICF and/or the small sam-
ple size at each measurement in this study.
Osteocalcin or bone gamma-carboxyglutamate protein
is a noncollagenous protein in the bone matrix. It is a
small (6000 Da) polypeptide. Monjo et al. [30] studied
372 implants in 93 rabbits, and suggested that osteocalcin
is the best biological marker for implant osseointegration
after 4-week healing periods. In our study, there were sta-
tistically significant increases in the OC level at 6, 8, 10,
and 12 weeks when compared with 1 week. These results
are similar to those of previous clinical studies. Slotte et al.
[31] studied gene expression of bone healing in PICF
using a quantitative real-time PCR technique [31]. Their
pilot study demonstrated that gene expression for OC was
high 7 weeks after implant placement. Prati et al. [32]
studied the release of bone markers during the osseointe-
gration period using the Luminex assay. They revealed
that OC level was high 8 weeks after implant placement in
their nonloaded group.
Regarding the relationship between the ISQ values and
ALP or OC levels, although the ISQ values were weakly
correlated with the bone markers (r = 0.226 for ALP
level and r = 0.245 for OC level, P = 0.05), there were sig-
nificant and positive correlations between the ISQ values
and ALP or OC levels at all measurements from week 1
to week 12. These results are in harmony with the find-
ings of a previous clinical study that investigated gene
expression of bone markers in PICF [31]. That pilot
study showed that ALP gene expression was correlated
with RFA at week 4 (r = 0.44, P = 0.03), and OC gene
expression was correlated with RFA at week 2 (r = 0.5,
P = 0.04). To our knowledge, correlations of the ISQ
value with the bone markers which were detected at
protein level in PICF are reported for the first time.
Vogel and Marcotte [33] suggested that the correlation
between mRNA and protein quantities is approximately
Fig. 8 There were moderately significant and positive correlations
between the ALP levels and OC levels at all measurements from
week 1 to week 12. The OC levels in pg/μg protein were associated
with the ALP levels in nM/μg protein at the implant site (a), control
site (b), and pooled samples of the control and implant sites (c)
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40%. As there are many mechanisms between transcrip-
tion and translation, especially in human cell and protein
stability, at the gene expression level, the transcription
data is beneficial in making decisions about molecular
candidates for future studies at the protein level. The
colorimetric assay and ELISA techniques utilized in this
study have many advantages, such as sensitivity, specifi-
city, speed, and compatibility with standard clinical labora-
tory equipment [34]. These techniques can be routinely
applied in clinical situations. Although the high sensitivity
and specificity of the quantitative, real-time, polymerase
chain reaction are justified [35], the limitations of this
technique are the sensitive nature of the work and the cost
of the chemicals and equipment.
Conclusions
Within the limitations of this study and cautious inter-
pretation due to small number of implants/patients, the
ISQ values were weakly correlated with both ALP and
OC molecules in PICF during the healing period. The
results also show that osteocalcin may be used as a bio-
logical marker for monitoring implant healing at 6, 8, 10,
and 12 weeks after implant placement. The ISQ values
showed high stability of dental implants used over the
healing period.
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